FDA Approves Gene Therapy, Adstiladrin, for Tough-to-Treat Bladder Cancer

MONDAY, Dec. 19, 2022 -- Patients with a high-risk bladder cancer now have a new option to treat it.
The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have...